Found: 419
Select item for more details and to access through your institution.
Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 1, p. 81, doi. 10.1007/s00592-020-01581-x
- By:
- Publication type:
- Article
A marker of type VI collagen formation (PRO-C6) is associated with higher arterial stiffness in type 1 diabetes.
- Published in:
- Acta Diabetologica, 2019, v. 56, n. 6, p. 711, doi. 10.1007/s00592-019-01306-9
- By:
- Publication type:
- Article
Techniques to Assess the Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Blood Volume in Patients with Diabetic Kidney Disease.
- Published in:
- Nephron, 2024, v. 148, n. 3, p. 137, doi. 10.1159/000534396
- By:
- Publication type:
- Article
Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease.
- Published in:
- Nephron, 2023, v. 147, n. 11, p. 673, doi. 10.1159/000531574
- By:
- Publication type:
- Article
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 2, p. 1, doi. 10.1093/gerona/glad181
- By:
- Publication type:
- Article
Effect of liraglutide on expression of inflammatory genes in type 2 diabetes.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97967-0
- By:
- Publication type:
- Article
Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.799915
- By:
- Publication type:
- Article
Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 9, p. 1298, doi. 10.3390/ph16091298
- By:
- Publication type:
- Article
Lower Blood Oxygen Saturation is Associated With Microvascular Complications in Individuals With Type 1 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 1, p. 99, doi. 10.1210/clinem/dgac559
- By:
- Publication type:
- Article
TMAO: Trimethylamine-N-Oxide or Time to Minimize Intake of Animal Products?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2020, v. 105, n. 7, p. 2275, doi. 10.1210/clinem/dgaa173
- By:
- Publication type:
- Article
Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01155-9
- By:
- Publication type:
- Article
Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-0995-x
- By:
- Publication type:
- Article
Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0917-y
- By:
- Publication type:
- Article
Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.
- Published in:
- Cardiovascular Diabetology, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12933-018-0705-0
- By:
- Publication type:
- Article
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
- Published in:
- Cardiovascular Diabetology, 2018, v. 17, n. 1, p. 1, doi. 10.1186/s12933-018-0697-9
- By:
- Publication type:
- Article
Urinary peptide analysis to predict the response to blood pressure medication.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 5, p. 873, doi. 10.1093/ndt/gfad223
- By:
- Publication type:
- Article
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 9, p. 2041, doi. 10.1093/ndt/gfad009
- By:
- Publication type:
- Article
Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 5, p. 1260, doi. 10.1093/ndt/gfac280
- By:
- Publication type:
- Article
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE).
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 4, p. 894, doi. 10.1093/ndt/gfac198
- By:
- Publication type:
- Article
Clinical implications and guidelines for CKD in type 2 diabetes.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 3, p. 542, doi. 10.1093/ndt/gfac285
- By:
- Publication type:
- Article
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 2, p. 372, doi. 10.1093/ndt/gfac157
- By:
- Publication type:
- Article
HbA1c and beyond.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 1, p. 34, doi. 10.1093/ndt/gfab243
- By:
- Publication type:
- Article
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 9, p. 1647, doi. 10.1093/ndt/gfab335
- By:
- Publication type:
- Article
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
- By:
- Publication type:
- Article
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 6, p. 1014, doi. 10.1093/ndt/gfaa294
- By:
- Publication type:
- Article
Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 1, p. 100, doi. 10.1093/ndt/gfaa308
- By:
- Publication type:
- Article
Effects of the chymase inhibitor fulacimstat in diabetic kidney disease—results from the CADA DIA trial.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 12, p. 2263, doi. 10.1093/ndt/gfaa299
- By:
- Publication type:
- Article
Major adverse renal events (MARE): a proposal to unify renal endpoints.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 3, p. 491, doi. 10.1093/ndt/gfz212
- By:
- Publication type:
- Article
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 2, p. 274, doi. 10.1093/ndt/gfz290
- By:
- Publication type:
- Article
Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes.
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, n. 4, p. 659, doi. 10.1093/ndt/gfy076
- By:
- Publication type:
- Article
Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 6, p. 779, doi. 10.3390/jcm8060779
- By:
- Publication type:
- Article
Is renal Na<sup>+</sup>,K<sup>+</sup>-ATPase a new target for renin–angiotensin blocking agents in diabetic nephropathy?
- Published in:
- Journal of Physiology, 2008, v. 586, n. 22, p. 5283, doi. 10.1113/jphysiol.2008.164723
- By:
- Publication type:
- Article
Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients.
- Published in:
- Metabolites (2218-1989), 2019, v. 9, n. 9, p. 184, doi. 10.3390/metabo9090184
- By:
- Publication type:
- Article
Improved prognosis of diabetic nephropathy in type 1 diabetes.
- Published in:
- Kidney International, 2015, v. 87, n. 2, p. 417, doi. 10.1038/ki.2014.206
- By:
- Publication type:
- Article
The Authors Reply:.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
- Published in:
- Kidney International, 2011, v. 79, n. 10, p. 1113, doi. 10.1038/ki.2010.554
- By:
- Publication type:
- Article
Need for better diabetes treatment for improved renal outcome.
- Published in:
- Kidney International, 2011, v. 79, p. S28, doi. 10.1038/ki.2010.513
- By:
- Publication type:
- Article
Effect of Sensor-Augmented Pump Treatment Versus Multiple Daily Injections on Albuminuria: A 1-Year Randomized Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01964-8
- By:
- Publication type:
- Article
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01949-7
- By:
- Publication type:
- Article
Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01891-8
- By:
- Publication type:
- Article
The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01652-z
- By:
- Publication type:
- Article
Effect of large weight reductions on measured and estimated kidney function.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
- Published in:
- Diabetologia, 2024, v. 67, n. 1, p. 3, doi. 10.1007/s00125-023-06015-1
- By:
- Publication type:
- Article
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2022, v. 65, n. 12, p. 1925, doi. 10.1007/s00125-022-05787-2
- By:
- Publication type:
- Article
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
- Published in:
- Diabetologia, 2022, v. 65, n. 7, p. 1085, doi. 10.1007/s00125-022-05694-6
- By:
- Publication type:
- Article
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
- Published in:
- Diabetologia, 2020, v. 63, n. 12, p. 2713, doi. 10.1007/s00125-020-05260-y
- By:
- Publication type:
- Article